Akzo Nobel (OTCMKTS:AKZOY – Get Free Report) was the target of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 11,200 shares, a decrease of 80.2% from the October 31st total of 56,700 shares. Based on an average trading volume of 230,600 shares, the short-interest ratio is currently 0.0 days.
Akzo Nobel Trading Down 2.1 %
Shares of AKZOY traded down $0.42 during mid-day trading on Wednesday, hitting $19.13. The company had a trading volume of 234,707 shares, compared to its average volume of 139,944. Akzo Nobel has a 1-year low of $19.08 and a 1-year high of $27.99. The business’s 50-day simple moving average is $21.76 and its 200-day simple moving average is $21.46. The stock has a market cap of $9.81 billion, a PE ratio of 16.16, a P/E/G ratio of 0.68 and a beta of 1.30. The company has a quick ratio of 0.89, a current ratio of 1.21 and a debt-to-equity ratio of 0.76.
Akzo Nobel (OTCMKTS:AKZOY – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The basic materials company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.04. The company had revenue of $2.93 billion for the quarter, compared to analyst estimates of $3.01 billion. Akzo Nobel had a net margin of 4.47% and a return on equity of 12.16%. Sell-side analysts forecast that Akzo Nobel will post 1.45 earnings per share for the current year.
Akzo Nobel Cuts Dividend
Akzo Nobel Company Profile
Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. The company operates through two segments: Decorative Paints and Performance Coatings. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings.
Further Reading
- Five stocks we like better than Akzo Nobel
- What is the Euro STOXX 50 Index?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stock Sentiment Analysis: How it Works
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Akzo Nobel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akzo Nobel and related companies with MarketBeat.com's FREE daily email newsletter.